This list is an analysis based on recent market events. It's not an investment recommendation.
About
Novogenia AG manufactures and sells personalized health products in global markets. The company offers products, such as personalized supplements and cosmetics; and services, including genetic testing, advanced therapies like personalized infusion therapies and reproductive genetics, and contract manufacturing. The company was formerly known as Darwin AG and changed its name to Novogenia AG in June 2026. The company was incorporated in 2021 and is based in Munich, Germany.
The current price of 7V0.MU is €6.50 EUR — it has increased by +2.36% in the past 24 hours. Watch Novogenia stock price performance more closely on the chart.
What is Novogenia stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Novogenia stocks are traded under the ticker 7V0.MU.
Is Novogenia stock price growing?▼
7V0.MU stock has risen by +2.36% compared to the previous week, the month change is a +9.24% rise, over the last year Novogenia has showed a +4% increase.
What is Novogenia market cap?▼
Today Novogenia has the market capitalization of 78M
What is Novogenia revenue for the last year?▼
Novogenia revenue for the last year amounts to 25.29M EUR.
What is Novogenia net income for the last year?▼
7V0.MU net income for the last year is 18.46M EUR.
Does Novogenia pay dividends?▼
Yes, 7V0.MU dividends are paid annual. The last dividend per share was 0.56 EUR. As of today, Dividend Yield (FWD)% is 8.62%.
How many employees does Novogenia have?▼
As of September 05, 2026, the company has 204 employees.
In which sector is Novogenia located?▼
Novogenia operates in the Other sector.
When did Novogenia complete a stock split?▼
The last stock split for Novogenia was on September 18, 2025 with a ratio of 3:1.